Author | Paul Barr, MD | OncLive

Author | Paul Barr, MD


Dr. Barr on Updated RESONATE Data in IGHV-Mutant CLL

June 20, 2019


Paul Barr, MD, medical director, Cancer Center Clinical Trials Office, and assistant professor, School of Medicine and Dentistry, University of Rochester, discusses the 6-year follow-up in patients with chronic lymphocytic leukemia (CLL) or small lymphocytic lymphoma (SLL) on ibrutinib (Imbruvica) as part of the RESONATE study.